Hadji-Turdeghal, K., Petersen, J. K., Graversen, P. L., Butt, J. H., Strange, J. E., Ihlemann, N., Dahl, J. S.
, Povlsen, J. A., Voldstedlund, M.
, Terkelsen, C. J., Møller, C. H., Freeman, P., Nissen, H., De Backer, O., Koeber, L., Østergaard, L. & Fosbøl, E. L. (2025).
Bacteraemia after transcatheter aortic valve implantation: a nationwide cohort study.
Heart,
111(9), 412-420.
https://doi.org/10.1136/heartjnl-2024-324803Vistisen, H. Ø., Graversen, P. L., Havers-Borgersen, E., Strange, J. E., Østergaard, L., Butt, J. H., Dahl, J. S.
, Povlsen, J. A., Terkelsen, C. J., Freeman, P., Nissen, H., Køber, L., de Backer, O. & Fosbøl, E. L. (2025).
Antithrombotic therapy following transcatheter aortic valve implantation: a Danish nationwide study.
European Heart Journal - Quality of Care & Clinical Outcomes,
11(5), 604-613.
https://doi.org/10.1093/ehjqcco/qcaf003Arslani, K., Engstrøm, T.
, Maeng, M., Kjøller-Hansen, L., Maehara, A., Zhou, Z., Ben-Yehuda, O.
, Bøtker, H. E., Matsumura, M., Mintz, G. S.
, Fröbert, O., Persson, J., Wiseth, R., Larsen, A. I., Jensen, L. O., Nordrehaug, J. E., Bleie, Ø., Omerovic, E., Held, C. ... Stone, G. W. (2025).
Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy.
JACC: Cardiovascular Imaging,
18(6), 696-706.
https://doi.org/10.1016/j.jcmg.2024.11.002Jacobsen, M. R., Jabbari, R.
, Grove, E. L., Mæng, M., Veien, K., Hougaard, M., Freeman, P., Kelbæk, H., Charlot, M. G., Engstrøm, T. & Sørensen, R. (2025).
Genotype-guided de-escalation and abbreviation of dual antiplatelet therapy in patients with myocardial infarction and high bleeding risk: Design and rationale of the investigator-initiated, multicenter, randomized, controlled trial, DAN-DAPT.
American Heart Journal,
285, 74-81.
https://doi.org/10.1016/j.ahj.2025.02.020Pedersen, O. B., Nissen, P. H., Pasalic, L.
, Hvas, A.-M., Kristensen, S. D. & Grove, E. L. (2025).
Changes in platelet maturity and reactivity following acute ST-segment elevation myocardial infarction.
Research and Practice in Thrombosis and Haemostasis,
9(1), Article 102652.
https://doi.org/10.1016/j.rpth.2024.102652
Dettling, A., Huber, K.
, Kristensen, S. D., Aradi, D., Schrage, B. & Clemmensen, P. (2025).
Antiplatelet therapy in acute myocardial infarction complicated by cardiogenic shock.
Clinical Research in Cardiology,
114(10), 1237-1245. Article e000590.
https://doi.org/10.1007/s00392-025-02619-2Stødkilde-Jørgensen, N., Olesen, K. K. W., Gyldenkerne, C., Hansen, M. K., Nielsen, R. R., Nielsen, J. C. & Maeng, M. (2025).
Mortality and use of implantable cardioverter defibrillators in patients with low ejection fraction following non-ST-segment elevation myocardial infarction.
Europace,
27(2), Article euaf036.
https://doi.org/10.1093/europace/euaf036,
https://doi.org/10.1093/europace/euaf036
Pedersen, S. S., Johansen, J. B.
, Nielsen, J. C., Larroude, C. E., Riahi, S., Melchior, T. M., Vinther, M., Skovbakke, S. J. & Skov, O. (2025).
Anxiety and depression in patients with an implantable cardioverter defibrillator: Do personality and ICD expectations play a role? General Hospital Psychiatry,
94, 145-149.
https://doi.org/10.1016/j.genhosppsych.2025.03.002